EGI
CLDX icon

EAM Global Investors’s Celldex Therapeutics CLDX Stock Holding History

EAM Global Investors’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-63,143
Closed -$2.27M – 90
2023
Q1 		$2.27M Sell
63,143
-8,911
-12% -$385K 0.64% 80
2022
Q4 		$3.21M Buy
+72,054
New +$2.57M 0.83% 27
2021
Q4 		– Sell
-96,528
Closed -$5.21M – 204
2021
Q3 		$5.21M Buy
96,528
+25,290
+36% +$1.19M 1.23% 6
2021
Q2 		$2.38M Buy
+71,238
New +$1.96M 0.66% 63
2021
Q1 		– Sell
-69,557
Closed -$1.22M – 149
2020
Q4 		$1.22M Sell
69,557
-29,193
-30% -$525K 0.33% 126
2020
Q3 		$1.46M Buy
+98,750
New +$1.16M 0.54% 95

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return